Malek M, Lynch W, Wells N, Elliott T, Bint A, Sanderson P, Jaderberg M, Davey P
Pharmacoeconomics Research Centre, University of Dundee, UK.
J Antimicrob Chemother. 1992 Feb;29(2):207-17. doi: 10.1093/jac/29.2.207.
This study compares the utilization costs of ceftazidime therapy with those of gentamicin in combination with other antibacterial drugs. The results show that the relatively high purchase cost of ceftazidime compared to combinations is more than counterbalanced by the additional materials used for drug administration and serum antibiotic assays, even when other drugs were combined with ceftazidime. The average drug and equipment costs were 230.13 pounds for ceftazidime regimens and 253.94 pounds for gentamicin regimens. It is also shown that ceftazidime therapy is associated with a reduction in personnel time compared to gentamicin regimens. The average times per patient for administration and assay were 1 h 43 min for ceftazidime and 4 h 57 min for gentamicin regimens. We conclude that ceftazidime regimens are cheaper than gentamicin regimens when all drug and equipment costs are quantified. Moreover, the use of ceftazidime will release staff time for other purposes.
本研究比较了头孢他啶疗法与庆大霉素联合其他抗菌药物的使用成本。结果表明,尽管其他药物与头孢他啶联合使用,但头孢他啶相比联合用药较高的采购成本,被药物给药和血清抗生素检测所用的额外材料成本所抵消。头孢他啶治疗方案的平均药物和设备成本为230.13英镑,庆大霉素治疗方案为253.94英镑。研究还表明,与庆大霉素治疗方案相比,头孢他啶疗法可减少人员时间。头孢他啶治疗方案每位患者给药和检测的平均时间为1小时43分钟,庆大霉素治疗方案为4小时57分钟。我们得出结论,当所有药物和设备成本都被量化时,头孢他啶治疗方案比庆大霉素治疗方案更便宜。此外,使用头孢他啶将使工作人员有时间用于其他目的。